0.14 EUR
1.02 M EUR
5.04 M EUR
About VYTRUS BIOTECH, S.A.
Sector
Industry
Headquarters
Barcelona
Website
Founded
2009
ISIN
ES0105618005
FIGI
BBG0160ZL316
Vytrus Biotech SA is a biotechnology company, which engages in the development of cosmetic active ingredients from plant stem cell technology. The company was founded by Òscar Expósito Tarrés and Albert Jané Font in June 2009 and is headquartered in Barcelona, Spain.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of VYT is 2.92 EUR — it hasn't changed in the past 24 hours. Watch VYTRUS BIOTECH, S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange VYTRUS BIOTECH, S.A. stocks are traded under the ticker VYT.
VYT stock hasn't changed in a week, the month change is a 4.29% rise, over the last year VYTRUS BIOTECH, S.A. has showed a 18.70% increase.
We've gathered analysts' opinions on VYTRUS BIOTECH, S.A. future price: according to them, VYT price has a max estimate of 3.28 EUR and a min estimate of 3.28 EUR. Watch VYT chart and read a more detailed VYTRUS BIOTECH, S.A. stock forecast: see what analysts think of VYTRUS BIOTECH, S.A. and suggest that you do with its stocks.
VYT stock is 0.00% volatile and has beta coefficient of 0.017. Track VYTRUS BIOTECH, S.A. stock price on the chart and check out the list of the most volatile stocks — is VYTRUS BIOTECH, S.A. there?
Yes, you can track VYTRUS BIOTECH, S.A. financials in yearly and quarterly reports right on TradingView.
VYT net income for the last half-year is 510.28 K EUR, while the previous report showed 510.72 K EUR of net income which accounts for −0.086% change. Track more VYTRUS BIOTECH, S.A. financial stats to get the full picture.
No, VYT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 37 employees. See our rating of the largest employees — is VYTRUS BIOTECH, S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VYTRUS BIOTECH, S.A. EBITDA is 1.81 M EUR, and current EBITDA margin is 34.45%. See more stats in VYTRUS BIOTECH, S.A. financial statements.
Like other stocks, VYT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VYTRUS BIOTECH, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VYTRUS BIOTECH, S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VYTRUS BIOTECH, S.A. stock shows the buy signal. See more of VYTRUS BIOTECH, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.